Yahoo Web Search

Search results

1. • 

     Terns reports progress in TERN-701 CML drug trial By Investing.com

     Investing.com· 19 hours ago

     Terns Pharmaceuticals, Inc. (NASDAQ:TERN), a biopharmaceutical company focusing on the development...

2. • Study identifies driver of liver cancer that could be target for treatment

     Medical Xpress· 4 days ago

     The molecule, said the researchers, could be a target for cancer treatment in the future. Hepatocellular carcinoma is a type of cancer that accounts for 90% of liver tumors ...

3. • 

     You Can't Ripen a Pineapple (No Matter What Everyone Says)

     The Kitchn via Yahoo News· 4 hours ago

     -climacteric fruits … ripen gradually, usually don’t store sugars as starch, and so depend on their...

4. • Horse-shaped nebula gets its close-up in new photos by NASA’s Webb telescope

     WFLA· 3 hours ago

     NASA’s Webb Space Telescope has revealed the sharpest images yet of a portion of a horse-shaped nebula, showing the “mane” in finer detail.

5. • Media Molecule’s Next Game is a New IP

     GameSpot· 6 days ago

     Media Molecule is working on a new game and it will be a completely new IP according to a recent job listing. The developer, known for feel-good franchises like LittleBigPlanet ...

6. • 

     PTSD tied to 95 'risk hotspots' in the genome

     Live Science via Yahoo News· 4 days ago

     Illustration of a dna molecule with different nucleotides highlighted. The world's largest-ever genetic study of post-traumatic stress disorder (PTSD)...

7. • 

     Researchers reveal how protein modifications power T cells

     Newswise· 2 days ago

     In our cells, molecules called phosphate groups are constantly attaching to—or detaching...

8. • Incyte Corp (INCY) Q1 2024 Earnings: Misses Revenue Estimates but Shows Strong Growth in ...

     GuruFocus.com via Yahoo Finance· 6 hours ago

     For a detailed view, readers can access the full 8-K filing. Company Overview Incyte, a global biopharmaceutical firm, is at the forefront of developing small-molecule drugs ...

9. • 

     Roche's pipeline rethink hits 20% of new molecules as cancer candidates join discard pile

     FierceBiotech· 6 days ago

     The culls are part of a broader refocusing that has removed 20% of new molecules from the pipeline...

10. • 

      AptarGroup, Inc. (NYSE:ATR) Q1 2024 Earnings Call Transcript

      Insider Monkey via Yahoo Finance· 5 hours ago

      AptarGroup, Inc. (NYSE:ATR) Q1 2024 Earnings Call Transcript April 26, 2024 AptarGroup, Inc. isn’t...